By Metro US
Posted on
TOKYO (Reuters) – Pfizer Inc said on Friday it received special approval in Japan for its COVID-19 vaccine to be given to children aged 5-11.
The mRNA-type vaccine developed by Pfizer and BioNTech SE has been the most commonly used in Japan for protection against the coronavirus so far.
(Reporting by Rocky Swift; Editing by Jacqueline Wong)
Man City beats Brighton 4-0 to stay on course for another Premier League title. Phil Foden scores 2
The NFL draft gives players a chance to flaunt their style on the red carpet
QB Jaden Rashada transfers to Georgia after leaving Arizona State
Suns’ Big 3 in a big pickle, down 2-0 against the Timberwolves as series moves to Phoenix
Charlie Woods, son of Tiger, shoots 81 in local qualifier and fails in bid to play in US Open
Tennessee lawmakers OK bill criminalizing adults who help minors receive gender-affirming care
Hamas again raises the possibility of a 2-state compromise. Israel and its allies aren’t convinced
These people were charged with interfering in the 2020 election. Some are still in politics today
Ukrainian duo heads to the Eurovision Song Contest with a message: We’re still here
Key moments from landmark Supreme Court arguments on Trump’s immunity claims
Minneapolis smokers to pay some of the highest cigarette prices in US with a $15 per-pack minimum
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
US births fell last year, marking an end to the late pandemic rebound, experts say
